Antigen depots
Nature Immunology
November 21, 2011
The effects of type 1 interferon (IFN), which is normally produced by mammalian cells following viral infection, are unexpectedly inhibited in specialized immune cells during vesicular stomatitis virus (VSV) infection, according to a report published in Nature Immunology. This finding could have implications for vaccine design. Usp18 is a host protein that dampens type 1 interferon signaling. Karl Sebastian Lang and colleagues show that specialized cells in the spleen, called metallophilic macrophages, express high amounts of Usp18. By inhibiting IFN, Usp18 allows viral replication in these cells, which is necessary for the generation of neutralizing antibodies and antiviral T cells. Interfering with the ‘antigen depot’ function of these cells leads to failure of the adaptive immune responses against VSV and viral dissemination to the central nervous system. Targeting vaccines to metallophilic macrophages could increase the chances of generating a protective adaptive immune response.
doi: 10.1038/ni.2169
Research highlights
-
Jun 30
Genomics: Gray wolf genome hints at dual ancestry of dogsNature
-
Jun 30
Evolution: Hawks learn on the fly to swoop up before perchingNature
-
Jun 30
Microbiology: Transmission of gastrointestinal viruses in salivaNature
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports